Alfredo García Layana-rekin lankidetzan egindako argitalpenak (8)

2022

  1. A Screening Tool for Self-Evaluation of Risk for Age-Related Macular Degeneration: Validation in a Spanish Population

    Translational Vision Science and Technology, Vol. 11, Núm. 6

2021

  1. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

    Acta ophthalmologica, Vol. 99, Núm. 8, pp. 861-870

2020

  1. Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study

    Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829

2017

  1. Prevalence of Vitreoretinal Interface Abnormalities on Spectral-Domain OCT in Healthy Participants over 45 Years of Age

    Ophthalmology Retina

2015

  1. Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration

    Journal of Ophthalmology, Vol. 2015

2014

  1. A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration

    Journal of Ophthalmology, Vol. 2014

  2. Do nutritional supplements have a role in age macular degeneration prevention?

    Journal of Ophthalmology, Vol. 2014

2011

  1. Myopic choroidal neovascularization

    Ophthalmology